Cargando…

Recombinant Protein-Based Nanoparticles: Elucidating Their Inflammatory Effects In Vivo and Their Potential as a New Therapeutic Format

Bacterial inclusion bodies (IBs) are protein-based nanoparticles of a few hundred nanometers formed during recombinant protein production processes in different bacterial hosts. IBs contain active protein in a mechanically stable nanostructured format that has been broadly characterized, showing pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gifre-Renom, Laia, Ugarte-Berzal, Estefania, Martens, Erik, Boon, Lise, Cano-Garrido, Olivia, Martínez-Núñez, Esther, Luque, Teresa, Roca-Pinilla, Ramon, Conchillo-Solé, Òscar, Ferrer-Miralles, Neus, Villaverde, Antonio, Opdenakker, Ghislain, Garcia-Fruitós, Elena, Arís, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284881/ https://www.ncbi.nlm.nih.gov/pubmed/32414218 http://dx.doi.org/10.3390/pharmaceutics12050450

Ejemplares similares

The Biological Potential Hidden in Inclusion Bodies
por: Gifre-Renom, Laia, et al.
Publicado: (2020)

Selecting Subpopulations of High-Quality Protein Conformers among Conformational Mixtures of Recombinant Bovine MMP-9 Solubilized from Inclusion Bodies
por: Carratalá, Jose Vicente, et al.
Publicado: (2021)

Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities
por: Boon, Lise, et al.
Publicado: (2016)

A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates
por: Gifre-Renom, L., et al.
Publicado: (2018)

Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017)

EDTA/gelatin zymography method to identify C1s versus activated MMP‐9 in plasma and immune complexes of patients with systemic lupus erythematosus
por: Ugarte‐Berzal, Estefania, et al.
Publicado: (2018)

MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2019)

Potential of MMP-9 based nanoparticles at optimizing the cow dry period: pulling apart the effects of MMP-9 and nanoparticles
por: Gifre-Renom, L., et al.
Publicado: (2020)

Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
por: Ugarte-Berzal, Estefania, et al.
Publicado: (2018)

Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria
por: Baltà-Foix, Ricardo, et al.
Publicado: (2023)

The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off
por: Parés, Sílvia, et al.
Publicado: (2021)

Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase
por: Vandooren, Jennifer, et al.
Publicado: (2018)

Trends in recombinant protein use in animal production
por: Gifre, Laia, et al.
Publicado: (2017)

Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Side effects of chaperone gene co-expression in recombinant protein production
por: Martínez-Alonso, Mónica, et al.
Publicado: (2010)

Physiological fibrin hydrogel modulates immune cells and molecules and accelerates mouse skin wound healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2023)

Propeptide glycosylation and galectin‐3 binding decrease proteolytic activation of human proMMP‐9/progelatinase B
por: Boon, Lise, et al.
Publicado: (2018)

Vessel Enlargement in Development and Pathophysiology
por: Gifre-Renom, Laia, et al.
Publicado: (2021)

A new generation of recombinant polypeptides combines multiple protein domains for effective antimicrobial activity
por: Roca-Pinilla, Ramon, et al.
Publicado: (2020)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Serna, Naroa, et al.
Publicado: (2021)

The future of recombinant host defense peptides
por: Roca-Pinilla, Ramon, et al.
Publicado: (2022)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Grillet, Bernard, et al.
Publicado: (2021)

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics
por: Carratalá, Jose V., et al.
Publicado: (2020)

Bacterial cell factories for recombinant protein production; expanding the catalogue
por: Ferrer-Miralles, Neus, et al.
Publicado: (2013)

Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity
por: Gifre-Renom, Laia, et al.
Publicado: (2022)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms
por: Nuti, Elisa, et al.
Publicado: (2020)

Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing
por: Pereira, Rafaela Vaz Sousa, et al.
Publicado: (2022)

Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
por: Vandooren, Jennifer, et al.
Publicado: (2017)

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases
por: Vandooren, Jennifer, et al.
Publicado: (2021)

Sequence edition of single domains modulates the final immune and antimicrobial potential of a new generation of multidomain recombinant proteins
por: Roca-Pinilla, Ramon, et al.
Publicado: (2021)

Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications
por: Roca-Pinilla, Ramon, et al.
Publicado: (2020)

Functional inclusion bodies produced in the yeast Pichia pastoris
por: Rueda, Fabián, et al.
Publicado: (2016)

Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells
por: Barguilla, Irene, et al.
Publicado: (2022)

The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells
por: González-Montalbán, Nuria, et al.
Publicado: (2006)

Title: insoluble proteins catch heterologous soluble proteins into inclusion bodies by intermolecular interaction of aggregating peptides
por: Carratalá, Jose Vicente, et al.
Publicado: (2021)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Microbial factories for recombinant pharmaceuticals
por: Ferrer-Miralles, Neus, et al.
Publicado: (2009)

Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B
por: Gounko, Natalia V., et al.
Publicado: (2016)

A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins
por: López-Cano, Adrià, et al.
Publicado: (2023)

Recombinant pharmaceuticals from microbial cells: a 2015 update
por: Sanchez-Garcia, Laura, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hqpghh6uc7dnl6jvipvn91et2d